1. Patents, Innovation and Access to New Pharmaceuticals
2. The flow of alliances and acquisitions is unending. The facts simply do not support any assumption that a few large companies are the only ones capable of or doing research in a field;There are journals dedicated to following these developments and deals. See, e.g., FIERCE BIOTECH
3. {BLR 2926} EC-IPLF-WWW